Antioxidant effects of resveratrol in the cardiovascular system
Top Cited Papers
- 6 May 2016
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 174 (12), 1633-1646
- https://doi.org/10.1111/bph.13492
Abstract
The antioxidant effects of resveratrol (3,5,4'-trihydroxy-trans-stilbene) contribute substantially to the health benefits of this compound. Resveratrol has been shown to be a scavenger of a number of free radicals. However, the direct scavenging activities of resveratrol are relatively poor. The antioxidant properties of resveratrol in vivo are more likely to be attributable to its effect as a gene regulator. Resveratrol inhibits NADPH oxidase-mediated production of ROS by down-regulating the expression and activity of the oxidase. This polyphenolic compound reduces mitochondrial superoxide generation by stimulating mitochondria biogenesis. Resveratrol prevents superoxide production from uncoupled endothelial nitric oxide synthase by up-regulating the tetrahydrobiopterin-synthesizing enzyme GTP cyclohydrolase I. In addition, resveratrol increases the expression of various antioxidant enzymes. Some of the gene-regulating effects of resveratrol are mediated by the histone/protein deacetylase sirtuin 1 or by the nuclear factor-E2-related factor-2. In this review article, we have also summarized the cardiovascular effects of resveratrol observed in clinical trials. This article is part of a themed section on Redox Biology and Oxidative Stress in Health and Disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.12/issuetoc.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (LI‐1042/3‐1, LI‐1042/1‐1)
This publication has 121 references indexed in Scilit:
- Nrf2and Cardiovascular DefenseOxidative Medicine and Cellular Longevity, 2013
- Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery DiseaseCardiovascular Drugs and Therapy, 2012
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP PhosphodiesterasesCell, 2012
- Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitriteBiochemical Pharmacology, 2010
- SIRT1-dependent regulation of chromatin and transcription: Linking NAD+ metabolism and signaling to the control of cellular functionsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenaseFree Radical Biology & Medicine, 2007
- Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic ratJournal of Molecular and Cellular Cardiology, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003